nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0568	0.0568	CcSEcCtD
Fesoterodine—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.0327	0.0327	CcSEcCtD
Fesoterodine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0322	0.0322	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0299	0.0299	CcSEcCtD
Fesoterodine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0285	0.0285	CcSEcCtD
Fesoterodine—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0281	0.0281	CcSEcCtD
Fesoterodine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0274	0.0274	CcSEcCtD
Fesoterodine—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0261	0.0261	CcSEcCtD
Fesoterodine—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0261	0.0261	CcSEcCtD
Fesoterodine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.0254	0.0254	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.0247	0.0247	CcSEcCtD
Fesoterodine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0232	0.0232	CcSEcCtD
Fesoterodine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0231	0.0231	CcSEcCtD
Fesoterodine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.023	0.023	CcSEcCtD
Fesoterodine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.0219	0.0219	CcSEcCtD
Fesoterodine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0218	0.0218	CcSEcCtD
Fesoterodine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0211	0.0211	CcSEcCtD
Fesoterodine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0205	0.0205	CcSEcCtD
Fesoterodine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.0201	0.0201	CcSEcCtD
Fesoterodine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.02	0.02	CcSEcCtD
Fesoterodine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0197	0.0197	CcSEcCtD
Fesoterodine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0187	0.0187	CcSEcCtD
Fesoterodine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0183	0.0183	CcSEcCtD
Fesoterodine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.018	0.018	CcSEcCtD
Fesoterodine—Cough—Riluzole—amyotrophic lateral sclerosis	0.0178	0.0178	CcSEcCtD
Fesoterodine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.0174	0.0174	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0173	0.0173	CcSEcCtD
Fesoterodine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.017	0.017	CcSEcCtD
Fesoterodine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0168	CcSEcCtD
Fesoterodine—Infection—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0165	CcSEcCtD
Fesoterodine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0163	0.0163	CcSEcCtD
Fesoterodine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0163	0.0163	CcSEcCtD
Fesoterodine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.0162	0.0162	CcSEcCtD
Fesoterodine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0151	CcSEcCtD
Fesoterodine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0148	CcSEcCtD
Fesoterodine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0147	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0144	CcSEcCtD
Fesoterodine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0144	CcSEcCtD
Fesoterodine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0142	0.0142	CcSEcCtD
Fesoterodine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0137	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0136	CcSEcCtD
Fesoterodine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0132	CcSEcCtD
Fesoterodine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0132	CcSEcCtD
Fesoterodine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0123	CcSEcCtD
Fesoterodine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.012	0.012	CcSEcCtD
Fesoterodine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0118	CcSEcCtD
Fesoterodine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0114	CcSEcCtD
Fesoterodine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.011	0.011	CcSEcCtD
Fesoterodine—Rash—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0105	CcSEcCtD
Fesoterodine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0105	CcSEcCtD
Fesoterodine—Headache—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0104	CcSEcCtD
Fesoterodine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00989	0.00989	CcSEcCtD
